Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Voyageur Pharmaceuticals Ltd V.VM

Alternate Symbol(s):  VYYRF

Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine Active Pharmaceutical Ingredients (API) and offers high-performance imaging contrast agents. The Company is focused on vertically integrating the barium and iodine contrast market, and aims at producing its own barium, iodine, and endo fullerenes. The Company’s products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. It also owns a 100% interest in the Frances Creek barium sulfate (barite) project, which is a rare grade mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.


TSXV:VM - Post by User

Comment by WarrantOfficeron Feb 12, 2021 3:10pm
126 Views
Post# 32555073

RE:RE:RE:What is status of C-60 project?

RE:RE:RE:What is status of C-60 project?This is from A PR dated 18 Nov 2020:

The Company issued a news release on May 11, 2020 that provided an update on the Company's C-60 - Fullerene project (the "Project"). The Company would like to clarify that the information provided in that news release was preliminary and a significant amount of due diligence and work is required to progress the Project or draw any conclusions about the Project's viability. Voyageur expects that due diligence and work on the Project will be continued after Covid 19 travel and quarantine restrictions are lifted, which at this time cannot be determined with any certainty. Currently Voyageur has no rights to the fullerene and has not been able to determine with any certainty that the Project is viable.

Investors should not consider the Project in their investment analysis of the Company. The letter of intent signed for the Project is non-binding. At this time, the Company cannot estimate when any binding agreements will be entered into and any such agreements will be dependent on the outcome of the due diligence and work referred to above.

Voyageur is focused on moving its Frances Creek barium sulfate project forward and the use of funds for near term financings are to be allocated for the Frances Creek project.

<< Previous
Bullboard Posts
Next >>